Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/naxJ7vHQeSw/
Wednesday 27 April 2011
US biogenerics policy makes me sad
I can only shake my head on days like today when I read about the state of biogenerics policy in the United States. The Wall Street Journal reports (Firms Push for Biotech Generics) that biotech companies are lined up against health plans and PBMs over the interpretation of the waiting period for biogenerics embedded in [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment